These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15072488)

  • 1. Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder.
    Krüger S; Thorns C; Böhle A; Feller AC
    Int Urol Nephrol; 2003; 35(2):169-73. PubMed ID: 15072488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
    Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.
    Cheng L; Neumann RM; Nehra A; Spotts BE; Weaver AL; Bostwick DG
    Cancer; 2000 Apr; 88(7):1663-70. PubMed ID: 10738225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
    J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Noack F; Böhle A; Feller AC
    Oncol Rep; 2004 Sep; 12(3):609-13. PubMed ID: 15289845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
    Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
    Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
    Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
    Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
    Hodgson A; Xu B; Satkunasivam R; Downes MR
    J Clin Pathol; 2018 Feb; 71(2):154-160. PubMed ID: 28768702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
    Hentschel AE; van Rhijn BWG; Bründl J; Compérat EM; Plass K; Rodríguez O; Henríquez JDS; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Scavarda-Lamberti A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Cohen D; Lunelli L; Cussenot O; Sheikh SE; Volanis D; Coté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Babjuk M; van der Kwast TH; Sylvester RJ
    Urol Oncol; 2020 May; 38(5):440-448. PubMed ID: 31704141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival.
    Jimenez RE; Gheiler E; Oskanian P; Tiguert R; Sakr W; Wood DP; Pontes JE; Grignon DJ
    Am J Surg Pathol; 2000 Jul; 24(7):980-7. PubMed ID: 10895820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.
    Santi R; Cai T; Nobili S; Galli IC; Amorosi A; Comperat E; Nesi G
    Virchows Arch; 2018 Apr; 472(4):605-613. PubMed ID: 29525824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
    Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
    J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
    van de Putte EEF; Bosschieter J; van der Kwast TH; Bertz S; Denzinger S; Manach Q; Compérat EM; Boormans JL; Jewett MAS; Stoehr R; van Leenders GJLH; Nieuwenhuijzen JA; Zlotta AR; Hendricksen K; Rouprêt M; Otto W; Burger M; Hartmann A; van Rhijn BWG
    BJU Int; 2018 Dec; 122(6):978-985. PubMed ID: 29637669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma.
    Bircan S; Candir O; Serel TA
    Urol Int; 2004; 73(3):201-8. PubMed ID: 15539837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.
    Leissner J; Koeppen C; Wolf HK
    J Urol; 2003 Mar; 169(3):955-60. PubMed ID: 12576821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma.
    Kir G; Cecikoglu GE; Topal CS; Sorkun MH; Culpan M; Suceken FY; Karaca H; Yildirim A
    Virchows Arch; 2023 Nov; 483(5):621-634. PubMed ID: 37632533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.